Cell Line : P-STS
Cellosaurus Index : CVCL_L298
Cellosaurus ID : P-STS
CTRP2 Name
: PSTS
Cancer Type : ns
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| P-STS | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| P-STS | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 17.0000 |
|
| P-STS | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | AA-COCF3 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| P-STS | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Alpelisib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| P-STS | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| P-STS | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| P-STS | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| P-STS | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| P-STS | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| P-STS | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K50799972 | CTRP2 | 0.0020 | 33.0000 |
|
| P-STS | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K55116708 | CTRP2 | 0.0020 | 33.0000 |
|
| P-STS | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| P-STS | BRD4132 | CTRP2 | 0.0049 | 80.0000 |
|
| P-STS | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| P-STS | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Carboplatin | CTRP2 | 0.0041 | 66.0000 |
|
| P-STS | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| P-STS | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | CD-437 | CTRP2 | 0.0011 | 18.0000 |
|
| P-STS | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| P-STS | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| P-STS | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| P-STS | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| P-STS | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| P-STS | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| P-STS | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| P-STS | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| P-STS | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Dabrafenib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| P-STS | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| P-STS | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| P-STS | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| P-STS | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Erlotinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| P-STS | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| P-STS | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| P-STS | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | FQI-2 | CTRP2 | 0.0010 | 2.1000 |
|
| P-STS | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| P-STS | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| P-STS | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| P-STS | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| P-STS | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| P-STS | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| P-STS | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| P-STS | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| P-STS | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | KU-0063794 | CTRP2 | 0.0020 | 33.0000 |
|
| P-STS | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | L-685458 | CTRP2 | 0.0180 | 18.0000 |
|
| P-STS | Lapatinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| P-STS | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| P-STS | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | MI-1 | CTRP2 | 0.0020 | 33.0000 |
|
| P-STS | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | MIRA-1 | CTRP2 | 0.0020 | 4.2000 |
|
| P-STS | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| P-STS | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| P-STS | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| P-STS | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| P-STS | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| P-STS | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| P-STS | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| P-STS | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| P-STS | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| P-STS | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Paclitaxel | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| P-STS | Pevonedistat | CTRP2 | 0.0180 | 18.0000 |
|
| P-STS | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| P-STS | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| P-STS | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| P-STS | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| P-STS | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| P-STS | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| P-STS | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| P-STS | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| P-STS | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| P-STS | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| P-STS | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| P-STS | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| P-STS | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| P-STS | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| P-STS | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| P-STS | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| P-STS | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| P-STS | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| P-STS | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| P-STS | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| P-STS | SN-38 | CTRP2 | 0.0000 | 1.3000 |
|
| P-STS | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| P-STS | Sorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| P-STS | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| P-STS | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Tanespimycin | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| P-STS | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Tivozanib | CTRP2 | 0.0004 | 13.0000 |
|
| P-STS | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Tretinoin | CTRP2 | 0.0041 | 66.0000 |
|
| P-STS | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| P-STS | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| P-STS | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | UNC0321 | CTRP2 | 0.0020 | 33.0000 |
|
| P-STS | UNC0638 | CTRP2 | 0.0010 | 17.0000 |
|
| P-STS | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | Venetoclax | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| P-STS | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| P-STS | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| P-STS | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| P-STS | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC